NuFACTOR Accepting Students’ Applications for 2017 Annual Eric Dostie Memorial College Scholarship
NuFACTORÂ is accepting applications for the 2017 Annual Eric Dostie Memorial College Scholarship. NuFACTOR is a specialty pharmacy of…
Articles by Margarida Azevedo, MSc
EU Panel Recommends Marketing Approval of Afstyla to Treat Hemophilia A
The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for…
In Phase 3 Trial of Hemophilia Therapy Emicizumab, 4 Patients Get Blood Clots
Four patients taking part in a Phase 3 clinical trial of Roche’s investigational hemophilia drug emicizumab (ACE910) have experienced serious …
Genentech Will Present New Clinical Data on Blood Diseases at ASH 2016
Genentech will present more than 60 abstracts at the 58th American Society of Hematology Annual Meeting (ASH 2016). Nine…
uniQure to Present Clinical Data from Study of AMT-060 in Hemophilia B at Upcoming ASH Meeting
uniQure, a company specializing in human gene therapy, will present clinical data from a Phase 1/2 dose-escalating study of…
Penn Researchers Coax Plants to Produce Human Clotting Factor for Hemophilia, Other Foreign Proteins
A research team from the departments of biochemistry and pathology at the University of Pennsylvania’s School of Dental Medicine has…
Study of Gene Therapy for Severe Hemophilia A to Resume Enrolling Patients in UK
The Medicines and Healthcare Products Regulatory Agency (MHRA) for the U.K. has approved the resumption of patient enrollment in BioMarin…
Virtual Reality Game Helping Young Hemophilia Patients Ignore Painful Treatments
The hemophilia team and design experts at Nationwide Children’s Hospital partnered with students from Ohio State University’s Advanced Computing Center…
50 Years of Progress in Treating Hemophilia Not Fully Evident in US, CDC Analysis Shows
Considerable progress has been made over the last 50 years in treating and caring for people with hemophilia but more…
Hemophilia B Treatment, Idelvion, Approved for Use in Japan
Japan’s Ministry of Health, Labor and Welfare has approved CSL Behring‘s Idelvion (albutrepenonacog alfa) for the prevention of bleeding tendency…